|

Zanubrutinib Oral Capsule Clinical Trials

1 actively recruiting trial

No change since May 2026

Also known as: Zanubrutinib (BGB-3111)

Pipeline

Phase 2: 1

Top Sponsors

  • The Lymphoma Academic Research Organisation1

Indications

Other1 trial

Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.